The complex roles of Wnt antagonists in RCC

Nature Reviews Urology

Volumn 8, Issue 12, 2011, Pages 690-699

  Saini, Sharanjot ^a   Majid, Shahana ^a   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; AXIN; BETA CATENIN; CASEIN KINASE I; DICKKOPF 1 PROTEIN; DICKKOPF 2 PROTEIN; DICKKOPF 3 PROTEIN; DICKKOPF 4 PROTEIN; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; GLYCOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LYMPHOCYTE ENHANCER FACTOR; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; PROTEIN INHIBITOR; SCLEROSTIN DOMAIN CONTAINING 1 PROTEIN; SECRETED FRIZZLED RELATED PROTEIN 1; SECRETED FRIZZLED RELATED PROTEIN 2; SECRETED FRIZZLED RELATED PROTEIN 3; SECRETED FRIZZLED RELATED PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN; WNT INHIBITORY FACTOR 1; WNT PROTEIN; WNT PROTEIN ANTAGONIST;

ANGIOGENESIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; DNA METHYLATION; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CARCINOMA, RENAL CELL; CELL CYCLE PROTEINS; DNA REPAIR; HUMANS; KIDNEY NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 83555173400     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2011.146     Document Type: Review

References (126)

1. Zambrano, N. R., Lubensky, I. A., Merino, M. J., Linehan, W. M. & Walther, M. M. Histopathology and molecular genetics of renal tumors toward unification of a classification system. J. Urol. 162, 1246-1258 (1999).
2. Rini, B. I., Rathmell, W. K. & Godley, P. Renal cell carcinoma. Curr. Opin. Oncol. 20, 300-306 (2008).
3. Pantuck, A. J., Zisman, A. & Belldegrun, A. S. The changing natural history of renal cell carcinoma. J. Urol. 166, 1611-1623 (2001).
4. Rini, B. I. & Bukowski, R. M. Targeted therapy for metastatic renal cell carcinoma: A home run or a work in progress? Oncology (Williston Park) 22, 388-396 (2008).
5. Banumathy, G. & Cairns, P. Signaling pathways in renal cell carcinoma. Cancer Biol. Ther. 10, 658-664 (2010).
6. Pavlovich, C. P. & Schmidt, L. S. Searching for the hereditary causes of renal-cell carcinoma. Nat. Rev. Cancer 4, 381-393 (2004).
7. Zbar, B., Klausner, R. & Linehan, W. M. Studying cancer families to identify kidney cancer genes. Annu. Rev. Med. 54, 217-233 (2003).
8. Nusse, R. Wnt signaling in disease and in development. Cell. Res. 15, 28-32 (2005).
9. van Amerongen, R., Mikels, A. & Nusse, R. Alternative Wnt signaling is initiated by distinct receptors. Sci. Signal 1, re9 (2008).
10. Bilic, J. et al. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 316, 1619-1622 (2007).
11. MacDonald, B. T., Tamai, K. & He, X. Wnt/β-catenin signaling: Components, mechanisms, and diseases. Dev. Cell 17, 9-26 (2009).
12. Behrens, J. et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642 (1996).
13. Moon, R. T., Kohn, A. D., De Ferrari, G. V. & Kaykas, A. WNT and β-catenin signalling: Diseases and therapies. Nat. Rev. Genet. 5, 691-701 (2004).
14. Chen, S. et al. Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription. J. Cell Biol. 152, 87-96 (2001).
15. Kuhl, M. The WNT/calcium pathway: Biochemical mediators, tools and future requirements. Front. Biosci. 9, 967-974 (2004).
16. Veeman, M. T., Axelrod, J. D. & Moon, R. T. A second canon. Functions and mechanisms of β-catenin-independent Wnt signaling. Dev. Cell 5, 367-377 (2003).
17. 2+ pathway to antagonize Wnt/β-catenin signaling. Mol. Cell. Biol. 23, 131-139 (2003).
18. 2+/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J. Biol. Chem. 275, 12701-12711 (2000).
19. Kawano, Y. & Kypta, R. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci. 116, 2627-2634 (2003).
20. Esteve, P. & Bovolenta, P. The advantages and disadvantages of Sfrp1 and Sfrp2 expression in pathological events. Tohoku J. Exp. Med. 221, 11-17 (2010).
21. Leyns, L., Bouwmeester, T., Kim, S. H., Piccolo, S. & De Robertis, E. M. Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell 88, 747-756 (1997).
22. Wang, S., Krinks, M., Lin, K., Luyten, F. P. & Moos, M. Jr. Frzb, a secreted protein expressed in the Spemann organizer, binds and inhibits Wnt-8. Cell 88, 757-766 (1997).
23. Melkonyan, H. S. et al. SARPs: A family of secreted apoptosis-related proteins. Proc. Natl Acad. Sci. USA 94, 13636-13641 (1997).
24. Hoang, B., Moos, M. Jr, Vukicevic, S. & Luyten, F. P. Primary structure and tissue distribution of FRZB, a novel protein related to Drosophila frizzled, suggest a role in skeletal morphogenesis. J. Biol. Chem. 271, 26131-26137 (1996).
25. Lin, K. et al. The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc. Natl Acad. Sci. USA 94, 11196-11200 (1997).
26. Rattner, A. et al. A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc. Natl Acad. Sci. USA 94, 2859-2863 (1997).
27. Kobayashi, K. et al. Secreted Frizzled-related protein 2 is a procollagen C proteinase enhancer with a role in fibrosis associated with myocardial infarction. Nat. Cell Biol. 11, 46-55 (2009).
28. Lee, H. X., Ambrosio, A. L., Reversade, B. & De Robertis, E. M. Embryonic dorsal-ventral signaling: Secreted frizzled-related proteins as inhibitors of tolloid proteinases. Cell 124, 147-159 (2006).
29. Lopez-Rios, J., Esteve, P., Ruiz, J. M. & Bovolenta, P. The Netrin-related domain of Sfrp1 interacts with Wnt ligands and antagonizes their activity in the anterior neural plate. Neural Dev. 3, 19 (2008).
30. Uren, A. et al. Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J. Biol. Chem. 275, 4374-4382 (2000).
31. Banyai, L. & Patthy, L. The NTR module: Domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci. 8, 1636-1642 (1999).
32. Chong, J. M., Uren, A., Rubin, J. S. & Speicher, D. W. Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules. J. Biol. Chem. 277, 5134-5144 (2002).
33. Matsuyama, M., Aizawa, S. & Shimono, A. Sfrp controls apicobasal polarity and oriented cell division in developing gut epithelium. PLoS Genet. 5, e1000427 (2009).
34. Sugiyama, Y. et al. Secreted frizzled-related protein disrupts PCP in eye lens fiber cells that have polarised primary cilia. Dev. Biol. 338, 193-201 (2009).
35. Rodriguez, J. et al. SFRP1 regulates the growth of retinal ganglion cell axons through the Fz2 receptor. Nat. Neurosci. 8, 1301-1309 (2005).
36. Mii, Y. & Taira, M. Secreted Frizzled-related proteins enhance the diffusion of Wnt ligands and expand their signalling range. Development 136, 4083-4088 (2009).
37. Leimeister, C., Bach, A. & Gessler, M. Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family. Mech. Dev. 75, 29-42 (1998).
38. Hsieh, J. C. et al. A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398, 431-436 (1999).
39. Rubin, J. S., Barshishat-Kupper, M., Feroze-Merzoug, F. & Xi, Z. F. Secreted WNT antagonists as tumor suppressors: Pro and con. Front. Biosci. 11, 2093-2105 (2006).
40. Piccolo, S. et al. The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature 397, 707-710 (1999).
41. Bafico, A., Liu, G., Yaniv, A., Gazit, A. & Aaronson, S. A. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat. Cell Biol. 3, 683-686 (2001).
42. Mao, B. et al. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411, 321-325 (2001).
43. Semenov, M. V. et al. Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr. Biol. 11, 951-961 (2001).
44. Glinka, A. et al. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature 391, 357-362 (1998).
45. Krupnik, V. E. et al. Functional and structural diversity of the human Dickkopf gene family. Gene 238, 301-313 (1999).
46. Brott, B. K. & Sokol, S. Y. Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol. Cell. Biol. 22, 6100-6110 (2002).
47. Hoang, B. H. et al. Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-β-catenin pathway. Cancer Res. 64, 2734-2739 (2004).
48. Mao, B. & Niehrs, C. Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 302, 179-183 (2003).
49. Mao, B. et al. Kremen proteins are Dickkopf receptors that regulate Wnt/β-catenin signalling. Nature 417, 664-667 (2002).
50. Semenov, M. V., Zhang, X. & He, X. DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. J. Biol. Chem. 283, 21427-21432 (2008).
51. Wang, K. et al. Characterization of the Kremen-binding site on Dkk1 and elucidation of the role of Kremen in Dkk-mediated Wnt antagonism. J. Biol. Chem. 283, 23371-23375 (2008).
52. Wu, W., Glinka, A., Delius, H. & Niehrs, C. Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/β-catenin signalling. Curr. Biol. 10, 1611-1614 (2000).
53. Zhu, W. et al. IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. Nature 454, 345-349 (2008).
54. Polakis, P. The many ways of Wnt in cancer. Curr. Opin. Genet. Dev. 17, 45-51 (2007).
55. Katoh, M. WNT/PCP signaling pathway and human cancer (review). Oncol. Rep. 14, 1583-1588 (2005).
56. Gumz, M. L. et al. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma. Clin. Cancer Res. 13, 4740-4749 (2007).
57. Dahl, E. et al. Frequent loss of SFRP1 expression in multiple human solid tumours: Association with aberrant promoter methylation in renal cell carcinoma. Oncogene 26, 5680-5691 (2007).
58. Awakura, Y., Nakamura, E., Ito, N., Kamoto, T. & Ogawa, O. Methylation-associated silencing of SFRP1 in renal cell carcinoma. Oncol. Rep. 20, 1257-1263 (2008).
59. Hsieh, S. Y., Hsieh, P. S., Chiu, C. T. & Chen, W. Y. Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene 23, 9183-9189 (2004).
60. Urakami, S. et al. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin. Cancer Res. 12, 6989-6997 (2006).
61. Urakami, S. et al. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection. Clin. Cancer Res. 12, 2109-2116 (2006).
62. Kawamoto, K. et al. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. Int. J. Cancer 123, 535-542 (2008).
63. Aguilera, O., Mu?oz, A., Esteller, M. & Fraga, M. F. Epigenetic alterations of the Wnt/β-catenin pathway in human disease. Endocr. Metab. Immune Disord. Drug Targets 7, 13-21 (2007).
64. Bilim, V. et al. Altered expression of β-catenin in renal cell cancer and transitional cell cancer with the absence of β-catenin gene mutations. Clin. Cancer Res. 6, 460-466 (2000).
65. Bohm, M., Wieland, I., Stinhofer, C., Otto, T. & Rubben, H. Detection of loss of heterozygosity in the APC tumor suppressor gene in nonpapillary renal cell carcinoma by microdissection and polymerase chain reaction. Urol. Res. 25, 161-165 (1997).
66. Janssens, N., Andries, L., Janicot, M., Perera, T. & Bakker, A. Alteration of frizzled expression in renal cell carcinoma. Tumour Biol. 25, 161-171 (2004).
67. Kim, Y. S. et al. β-catenin expression and mutational analysis in renal cell carcinomas. Pathol. Int. 50, 725-730 (2000).
68. Shiina, H. et al. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Clin. Cancer Res. 9, 2121-2132 (2003).
69. Suzuki, H. et al. Mutational state of von Hippel-Lindau and adenomatous polyposis coli genes in renal tumors. Oncology 54, 252-257 (1997).
70. Ueda, M. et al. Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas. Br. J. Cancer 85, 64-68 (2001).
71. Zang, T., Zhuang, L., Zhang, Z., Xin, D. & Guo, Y. Expression of β-catenin in renal cell carcinoma. Chin. Med. J. (Engl.) 114, 152-154 (2001).
72. Qian, C. N. et al. Cystic renal neoplasia following conditional inactivation of Apc in mouse renal tubular epithelium. J. Biol. Chem. 280, 3938-3945 (2005).
73. Saadi-Kheddouci, S. et al. Early development of polycystic kidney disease in transgenic mice expressing an activated mutant of the β-catenin gene. Oncogene 20, 5972-5981 (2001).
74. Sansom, O. J., Griffiths, D. F., Reed, K. R., Winton, D. J. & Clarke, A. R. Apc deficiency predisposes to renal carcinoma in the mouse. Oncogene 24, 8205-8210 (2005).
75. Peruzzi, B., Athauda, G. & Bottaro, D. P. The von Hippel-Lindau tumor suppressor gene product represses oncogenic β-catenin signaling in renal carcinoma cells. Proc. Natl Acad. Sci. USA 103, 14531-14536 (2006).
76. Major, M. B. et al. Wilms tumor suppressor WTX negatively regulates WNT/β-catenin signaling. Science 316, 1043-1046 (2007).
77. Ying, Y. & Tao, Q. Epigenetic disruption of the WNT/β-catenin signaling pathway in human cancers. Epigenetics 4, 307-312 (2009).
78. Hirata, H. et al. Role of secreted frizzled-related protein 3 in human renal cell carcinoma. Cancer Res. 70, 1896-1905 (2010).
79. Saini, S. et al. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas. Cancer Res. 69, 6815-6822 (2009).
80. Shi, Y., He, B., You, L. & Jablons, D. M. Roles of secreted frizzled-related proteins in cancer. Acta Pharmacol. Sin. 28, 1499-1504 (2007).
81. Ueno, K. et al. IGFBP-4 activates the Wnt/β-catenin signaling pathway and induces M-CAM expression in human renal cell carcinoma. Int. J. Cancer (2011).
82. Dennis, S., Aikawa, M., Szeto, W., d'Amore, P. A. & Papkoff, J. A secreted frizzled related protein, FrzA, selectively associates with Wnt-1 protein and regulates Wnt-1 signaling. J. Cell Sci. 112 (Pt 21), 3815-3820 (1999).
83. Caldwell, G. M. et al. The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res. 64, 883-888 (2004).
84. Fukui, T. et al. Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene 24, 6323-6327 (2005).
85. Veeck, J. et al. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 25, 3479-3488 (2006).
86. Takada, T. et al. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci. 95, 741-744 (2004).
87. Yoshino, K. et al. Secreted Frizzled-related proteins can regulate metanephric development. Mech. Dev. 102, 45-55 (2001).
88. Cheng, Y. Y. et al. Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br. J. Cancer 97, 895-901 (2007).
89. Huang, Z., Li, L. & Wang, J. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig. Dis. Sci. 52, 2287-2291 (2007).
90. Veeck, J. et al. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Mol. Cancer 7, 83 (2008).
91. Yamamura, S. et al. Oncogenic functions of secreted Frizzled-related protein 2 in human renal cancer. Mol. Cancer Ther. 9, 1680-1687 (2010).
92. Wang, S., Krinks, M. & Moos, M. Jr. Frzb-1, an antagonist of Wnt-1 and Wnt-8, does not block signaling by Wnts -3A, -5A, or -11. Biochem. Biophys. Res. Commun. 236, 502-504 (1997).
93. Kongkham, P. N. et al. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma. Oncogene 29, 3017-3024 (2010).
94. Mandal, D. et al. Severe suppression of Frzb/sFRP3 transcription in osteogenic sarcoma. Gene 386, 131-138 (2007).
95. Zi, X. et al. Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness. Cancer Res. 65, 9762-9770 (2005).
96. Suzuki, H. et al. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet. 31, 141-149 (2002).
97. Kawakami, K. et al. Secreted frizzled-related protein-5 is epigenetically downregulated and functions as a tumor suppressor in kidney cancer. Int. J. Cancer 128, 541-550 (2011).
98. Kawakami, K. et al. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer. Cancer Res. 69, 8603-8610 (2009).
99. Urakami, S. et al. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway. Clin. Cancer Res. 12, 383-391 (2006).
100. Pietila, I. et al. Secreted Wnt antagonist Dickkopf-1 controls kidney papilla development coordinated by Wnt-7b signalling. Dev. Biol. 353, 50-60 (2011).
101. Hirata, H. et al. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma. Int. J. Cancer 128, 1793-1803 (2010).
102. Shou, J. et al. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene 21, 878-889 (2002).
103. Wang, J., Shou, J. & Chen, X. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene 19, 1843-1848 (2000).
104. Mukhopadhyay, M. et al. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse. Dev. Cell 1, 423-434 (2001).
105. Hirata, H. et al. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Clin. Cancer Res. 15, 5678-5687 (2009).
106. Hirata, H. et al. Wnt antagonist gene polymorphisms and renal cancer. Cancer 115, 4488-4503 (2009).
107. Kurose, K. et al. Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J. Urol. 171, 1314-1318 (2004).
108. Ueno, K. et al. Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma. Mol. Carcinog. 50, 449-457 (2011).
109. Hirata, H. et al. DICKKOPF-4 activates the noncanonical c-Jun-NH2 kinase signaling pathway while inhibiting the Wnt-canonical pathway in human renal cell carcinoma. Cancer 117, 1649-1660 (2011).
110. Matsui, A. et al. DICKKOPF-4 and -2 genes are upregulated in human colorectal cancer. Cancer Sci. 100, 1923-1930 (2009).
111. Itasaki, N. et al. Wise, a context-dependent activator and inhibitor of Wnt signalling. Development 130, 4295-4305 (2003).
112. Clausen, K. A. et al. SOSTDC1 differentially modulates Smad and β-catenin activation and is down-regulated in breast cancer. Breast Cancer Res. Treat. 129, 737-746 (2011).
113. Blish, K. R. et al. A human bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol. Biol. Cell 19, 457-464 (2008).
114. Blish, K. R. et al. Loss of heterozygosity and SOSTDC1 in adult and pediatric renal tumors. J. Exp. Clin. Cancer Res. 29, 147 (2010).
115. Klein, C. A. Cancer. The metastasis cascade. Science 321, 1785-1787 (2008).
116. Fukuhara, K. et al. Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. J. Clin. Endocrinol. Metab. 87, 1729-1736 (2002).
117. Joesting, M. S. et al. Secreted frizzled related protein 1 is a paracrine modulator of epithelial branching morphogenesis, proliferation, and secretory gene expression in the prostate. Dev. Biol. 317, 161-173 (2008).
118. Joesting, M. S. et al. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Res. 65, 10423-10430 (2005).
119. Roth, W. et al. Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 19, 4210-4220 (2000).
120. Lee, J. L., Lin, C. T., Chueh, L. L. & Chang, C. J. Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis: A possible mechanism of mammary tumorigenesis. J. Biol. Chem. 279, 14602-14609 (2004).
121. Kress, E., Rezza, A., Nadjar, J., Samarut, J. & Plateroti, M. The frizzled-related sFRP2 gene is a target of thyroid hormone receptor a1 and activates β-catenin signaling in mouse intestine. J. Biol. Chem. 284, 1234-1241 (2009).
122. Wirths, O. et al. Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors. Lab. Invest. 83, 429-434 (2003).
123. Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E. & Lopez-Rios, J. Beyond Wnt inhibition: New functions of secreted Frizzled-related proteins in development and disease. J. Cell Sci. 121, 737-746 (2008).
124. Satoh, W., Gotoh, T., Tsunematsu, Y., Aizawa, S. & Shimono, A. Sfrp1 and Sfrp2 regulate anteroposterior axis elongation and somite segmentation during mouse embryogenesis. Development 133, 989-999 (2006).
125. Martin-Manso, G. et al. sFRP-1 binds via its netrin-related motif to the N-module of thrombospondin-1 and blocks thrombospondin-1 stimulation of MDA-MB-231 breast carcinoma cell adhesion and migration. Arch. Biochem. Biophys. 509, 147-156 (2011).
126. Esteve, P. et al. SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis. Nat. Neurosci. 14, 562-569 (2011).